VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Canaccord Adams Diabetes and Obesity Conference on Tuesday, May 12, 2009 at 8:20 AM (EDT) at the InterContinental Barclay Hotel in New York City.
